Medarex News
Most Popular Medarex Story
Bristol-Myers to buy Medarex for $2.1B
Anxious to beef up its pipeline, Bristol-Myers Squibb announced late Wednesday that it had struck a deal to buy Medarex for $2.4 billion. But the dealmakers note that the $300 million on Medarex's Read more...
Latest Headlines
- February 1, 2010
- August 4, 2009
- July 23, 2009
- June 22, 2009
- May 14, 2009
- April 21, 2009
- June 3, 2008
- April 28, 2008
- April 2, 2008
- November 8, 2007
- October 26, 2007
- November 7, 2006
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
